Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
AstraZeneca
Harvard Business School
Moodys
Baxter
Dow
Fuji
Accenture

Generated: November 15, 2018

DrugPatentWatch Database Preview

Indium in-111 oxyquinoline - Generic Drug Details

« Back to Dashboard

What are the generic sources for indium in-111 oxyquinoline and what is the scope of indium in-111 oxyquinoline freedom to operate?

Indium in-111 oxyquinoline is the generic ingredient in one branded drug marketed by Bwxt Itg and Ge Healthcare, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for indium in-111 oxyquinoline. One supplier is listed for this compound.

Summary for indium in-111 oxyquinoline
US Patents:0
Tradenames:1
Applicants:2
NDAs:2
Drug Master File Entries: 23
Suppliers / Packagers: 1
DailyMed Link:indium in-111 oxyquinoline at DailyMed

US Patents and Regulatory Information for indium in-111 oxyquinoline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare INDIUM IN 111 OXYQUINOLINE indium in-111 oxyquinoline INJECTABLE;INJECTION 019044-001 Dec 24, 1985 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bwxt Itg INDIUM IN 111 OXYQUINOLINE indium in-111 oxyquinoline INJECTABLE;INJECTION 202586-001 Jul 25, 2018 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
AstraZeneca
Harvard Business School
Moodys
Baxter
Dow
Fuji
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.